FDA re­ports more short­ages of drugs used to put Covid-19 pa­tients on ven­ti­la­tors

In­creas­ing de­mand for seda­tives used to help put Covid-19 pa­tients on­to ven­ti­la­tors means the FDA added two more — this time the in­jecta­bles propo­fol and dexmedeto­mi­dine — to its list of drug short­ages.

The propo­fol short­age was al­so pre­vi­ous­ly list­ed by the Amer­i­can So­ci­ety for Health-Sys­tem Phar­ma­cists (ASHP) ear­li­er this month, with man­u­fac­tur­ers not­ing in­creased de­mand. Michael Ganio, se­nior di­rec­tor of phar­ma­cy prac­tice and qual­i­ty at ASHP, pre­vi­ous­ly told Fo­cus via email: “We have mul­ti­ple re­ports of in­creas­es in pur­chas­es and uti­liza­tion of seda­tives like mi­da­zo­lam, fen­tanyl, and propo­fol to treat COVID-19 pa­tients who re­quire me­chan­i­cal ven­ti­la­tion.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.